Literature DB >> 20636986

Evaluation of acute congestive heart failure in dogs and cats: 145 cases (2007-2008).

Caroline M Goutal1, Iain Keir, Shale Kenney, John E Rush, Lisa M Freeman.   

Abstract

OBJECTIVE: To characterize the clinical presentation, management, and in-hospital outcomes of dogs and cats diagnosed with acute congestive heart failure (CHF).
DESIGN: Retrospective study of animals seen between January 2007 and May 2008.
SETTING: Emergency service at a university teaching hospital. ANIMALS: Ninety dogs and 55 cats with CHF.
MEASUREMENTS AND MAIN RESULTS: Patient characteristics, including age, clinical signs, clinicopathologic abnormalities, diagnostic testing, and outcome were recorded. Forty-eight of the animals already were receiving cardiac medications at the time of presentation. The most common diseases represented were chronic valvular disease and cardiomyopathies. Cats had significantly lower median body temperature at admission compared with dogs (P<0.001). The most common abnormalities were elevated lactate (64%), elevated BUN (52%), hypochloremia (31%), hyperglycemia (27%), and elevated liver enzymes (26%). Many of these became even more prevalent during hospitalization. One hundred and sixteen animals were discharged from the hospital, for a survival rate of 80%. There was no survival difference between dogs and cats (P=0.39). Dogs that developed hypokalemia during hospital stay (P=0.04) were more likely to survive compared with those without hypokalemia and initial body temperature was lower for those cats that did not survive (P=0.02). Of those that did not survive, the majority were euthanized (n=25), while 4 dogs died.
CONCLUSIONS: Dogs and cats presented to the emergency service with CHF had a high survival rate. In cats, initial body temperature was lower for those cats that did not survive. Although clinicopathologic abnormalities were common in both species, only dogs with hypokalemia had improved survival to hospital discharge.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20636986     DOI: 10.1111/j.1476-4431.2010.00524.x

Source DB:  PubMed          Journal:  J Vet Emerg Crit Care (San Antonio)        ISSN: 1476-4431


  6 in total

1.  Association between Survival Time and Changes in NT-proBNP in Cats Treated for Congestive Heart Failure.

Authors:  K V Pierce; J E Rush; L M Freeman; S M Cunningham; V K Yang
Journal:  J Vet Intern Med       Date:  2017-03-31       Impact factor: 3.333

2.  Prognostic value of lactate in cats presented in respiratory distress to the emergency room.

Authors:  Cassandra Gilday; Liz Guieu
Journal:  Front Vet Sci       Date:  2022-09-13

3.  Increased canine pancreatic lipase immunoreactivity (cPLI) and 1,2-o-dilauryl-rac-glycero-3-glutaric acid-(6'-methylresorufin) ester (DGGR) lipase in dogs with evidence of portal hypertension and normal pancreatic histology: a pilot study.

Authors:  Gonçalo Serrano; Dominique Paepe; Tim Williams; Penny Watson
Journal:  J Vet Diagn Invest       Date:  2021-04-02       Impact factor: 1.279

4.  Cardiovascular-renal axis disorders in the domestic dog and cat: a veterinary consensus statement.

Authors:  J L Pouchelon; C E Atkins; C Bussadori; M A Oyama; S L Vaden; J D Bonagura; V Chetboul; L D Cowgill; J Elliot; T Francey; G F Grauer; V Luis Fuentes; N Sydney Moise; D J Polzin; A M Van Dongen; N Van Israël
Journal:  J Small Anim Pract       Date:  2015-09       Impact factor: 1.522

5.  Clinical use of submaximal treadmill exercise testing and assessments of cardiac biomarkers NT-proBNP and cTnI in dogs with presymptomatic mitral regurgitation.

Authors:  Leona Wall; Annika Mohr; Florenza Lüder Ripoli; Nayeli Schulze; Camila Duarte Penter; StephanOscar Hungerbuehler; Jan-Peter Bach; Karin Lucas; Ingo Nolte
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

6.  Cardiovascular-renal axis disorder and acute-phase proteins in cats with congestive heart failure caused by primary cardiomyopathy.

Authors:  Mengmeng Liu; Liza S Köster; Geoffrey T Fosgate; Christopher C Chadwick; Íñigo Sanz-González; Peter David Eckersall; Paul R Wotton; Anne T French
Journal:  J Vet Intern Med       Date:  2020-05-12       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.